DK165988C - Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c - Google Patents

Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c

Info

Publication number
DK165988C
DK165988C DK332684A DK332684A DK165988C DK 165988 C DK165988 C DK 165988C DK 332684 A DK332684 A DK 332684A DK 332684 A DK332684 A DK 332684A DK 165988 C DK165988 C DK 165988C
Authority
DK
Denmark
Prior art keywords
modified
eglines
procedures
preparing
pharmaceutical preparations
Prior art date
Application number
DK332684A
Other languages
Danish (da)
English (en)
Other versions
DK332684D0 (da
DK165988B (da
DK332684A (da
Inventor
Ursula Seemueller
Johannes Dodt
Hans Fritz
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK332684D0 publication Critical patent/DK332684D0/da
Publication of DK332684A publication Critical patent/DK332684A/da
Publication of DK165988B publication Critical patent/DK165988B/da
Application granted granted Critical
Publication of DK165988C publication Critical patent/DK165988C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Paper (AREA)
DK332684A 1983-07-07 1984-07-06 Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c DK165988C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3324534 1983-07-07
DE3324534A DE3324534A1 (de) 1983-07-07 1983-07-07 Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel

Publications (4)

Publication Number Publication Date
DK332684D0 DK332684D0 (da) 1984-07-06
DK332684A DK332684A (da) 1985-01-08
DK165988B DK165988B (da) 1993-02-22
DK165988C true DK165988C (da) 1993-07-26

Family

ID=6203414

Family Applications (1)

Application Number Title Priority Date Filing Date
DK332684A DK165988C (da) 1983-07-07 1984-07-06 Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c

Country Status (10)

Country Link
US (1) US4636489A (el)
EP (1) EP0134479B1 (el)
JP (1) JPH0670077B2 (el)
AT (1) ATE32728T1 (el)
CA (1) CA1230069A (el)
DE (2) DE3324534A1 (el)
DK (1) DK165988C (el)
ES (1) ES534098A0 (el)
GR (1) GR82243B (el)
IE (1) IE57698B1 (el)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342373B1 (en) * 1983-11-21 2002-01-29 Ucp Gen-Pharma Ag Process for preparing recombinant eglin, protease inhibitor
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
US5166134A (en) * 1986-12-24 1992-11-24 John Lezdey Treatment of allergic rhinitis
US5180667A (en) * 1988-03-07 1993-01-19 Ciba-Geigy Corporation Genes encoding eglin C mutants
ES2063161T3 (es) * 1988-03-07 1995-01-01 Ciba Geigy Ag Proteinas modificadas.
DE68919848T2 (de) * 1988-05-27 1995-05-04 Philadelphia Children Hospital Amphiphile peptide und deren verwendung.
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
EP0347376B1 (en) * 1988-06-11 1994-03-23 Ciba-Geigy Ag Novel polypeptides with an anticoagulant activity
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
EP0514464A4 (en) * 1990-02-08 1993-04-28 Magainin Sciences, Inc. Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
JPH05507273A (ja) * 1990-05-14 1993-10-21 マゲイニン　サイエンセズ　インコーポレーテッド Ｄアミノ酸残基を有する生物活性ペプチドの組成物およびそれによる治療方法
EP0559647A1 (en) * 1990-06-27 1993-09-15 Magainin Pharmaceuticals Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
EP0587799B1 (en) * 1991-05-23 1999-07-07 Merrell Pharmaceuticals Inc. Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
CA2120337A1 (en) * 1991-10-16 1993-04-17 Michael A. Zasloff Composition and treatment with biologically active peptides and antibiotic
HU221310B1 (en) * 1994-06-02 2002-09-28 Merrell Pharma Inc Acylated enol di and tripeptide derivatives, their use and pharmaceutical compositions comprising thereof
CA2189526C (en) * 1994-06-02 2001-02-27 William A. Metz, Jr. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
EP0929577B1 (en) 1996-09-24 2003-06-04 The Procter & Gamble Company Stabilized proteinaceous protease inhibitors and variants thereof
US7001884B2 (en) * 2001-06-18 2006-02-21 Regents Of The University Of Michigan Eglin c based drugs for treatment of disease
DE102005007313A1 (de) * 2005-02-17 2006-08-24 Wacker Chemie Ag Verfahren zur Herstellung von Entschäumerformulierungen
KR101237116B1 (ko) * 2010-11-12 2013-02-25 대한유화공업 주식회사 내충격성 및 내압특성이 우수한 폴리프로필렌 조성물
CN110551707A (zh) * 2019-10-17 2019-12-10 山西大学 一种纯化中性或碱性蛋白酶的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808396C2 (de) * 1978-02-27 1984-04-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Protease-Inhibitoren
US4250086A (en) * 1979-11-19 1981-02-10 Ortho Pharmaceutical Corporation Method and composition for preparation of H-SAR-LYS-SAR-GLN-NH2

Also Published As

Publication number Publication date
JPH0670077B2 (ja) 1994-09-07
DK332684D0 (da) 1984-07-06
EP0134479B1 (de) 1988-03-02
CA1230069A (en) 1987-12-08
ES8601108A1 (es) 1985-10-16
ATE32728T1 (de) 1988-03-15
IE841734L (en) 1985-01-07
EP0134479A1 (de) 1985-03-20
ES534098A0 (es) 1985-10-16
DK165988B (da) 1993-02-22
GR82243B (el) 1984-12-13
IE57698B1 (en) 1993-03-10
DE3469534D1 (en) 1988-04-07
JPS60105699A (ja) 1985-06-11
DE3324534A1 (de) 1985-01-17
US4636489A (en) 1987-01-13
DK332684A (da) 1985-01-08

Similar Documents

Publication Publication Date Title
DK165988C (da) Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c
DK160614C (da) Analogifremgangsmaade til fremstilling af vinblastinderivater og farmaceutisk acceptable salte deraf
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
DK552684A (da) Desulfatohirudiner samt deres fremstilling og anvendelse
DK573384A (da) Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater
DK81583D0 (da) Derivater af 3-hydroxysmoersyre og fremgangsmade til fremstilling deraf
NO812933L (no) Aminosyrederivater, fremgangsmaate til deres fremstilling, midler som inneholder forbindelsene samt deres anvendelse
DK130683D0 (da) Derivater af bicycliske aminosyrer, fremgangsmader til fremstilling deraf, midler indeholdende disse forbindelser og deres anvendelse samt bicycliske aminosyrer som mellemprodukter og fremgangsmade til fremstilling heraf
DK93685D0 (da) Benzisoselenazolthioner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
DK222688A (da) Vaesker til konditionering af tand- og knoglestoffer, deres fremstilling og anvendelse
DK1089968T3 (da) Thyroideahormonanaloger og fremgangsmåder til deres fremstilling
NO921382D0 (no) Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene
DK11187D0 (da) Dna-sekvenser der koder for proteiner med husi-type i inhibitorers biologiske aktivitet, biotekniske fremgangsmaader til fremstilling af proteinerne o g farmaceutiske praeparater der indeholder dem
DK0658585T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og midler indeholdende disse som antik
DK494684D0 (da) Benzensulfonyl-lactamer, fremgangsmaade til deres fremstilling og deres anvendelse som aktiv komponent i framaceutiske kompositioner
NO821841L (no) Mettede aminocyklitderivater, deres fremstilling og legemiddel inneholdende dem
DK319384D0 (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK630088A (da) Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it
DK209284A (da) Dihydropyridiner, farmaceutiske kompositioner indeholdende disse, fremgangsmaade til forbindelsernes fremstilling og mellemprodukter anvendelige ved denne fremgangsmaade
JPS51136602A (en) Process for preparation of amino acid or peptide
DK454185A (da) Aminosyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner